BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27465340)

  • 21. Prognostic factors for mental retardation in patients with tuberous sclerosis complex.
    Chou PC; Chang YJ
    Acta Neurol Taiwan; 2004 Mar; 13(1):10-3. PubMed ID: 15315295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gadolinium-DTPA enhanced MR imaging in tuberous sclerosis.
    Martin N; Debussche C; De Broucker T; Mompoint D; Marsault C; Nahum H
    Neuroradiology; 1990; 31(6):492-7. PubMed ID: 2352631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CT and MR imaging of cerebral tuberous sclerosis.
    Inoue Y; Nemoto Y; Murata R; Tashiro T; Shakudo M; Kohno K; Matsuoka O; Mochizuki K
    Brain Dev; 1998 Jun; 20(4):209-21. PubMed ID: 9661965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central nervous system manifestations of tuberous sclerosis complex.
    Lu DS; Karas PJ; Krueger DA; Weiner HL
    Am J Med Genet C Semin Med Genet; 2018 Sep; 178(3):291-298. PubMed ID: 30230171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sporadic lymphangioleiomyomatosis and tuberous sclerosis complex with lymphangioleiomyomatosis: comparison of CT features.
    Avila NA; Dwyer AJ; Rabel A; Moss J
    Radiology; 2007 Jan; 242(1):277-85. PubMed ID: 17105849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristic brain magnetic resonance imaging (MRI) findings in neonates with tuberous sclerosis complex.
    Arca G; Pacheco E; Alfonso I; Duchowny MS; Melnick SJ
    J Child Neurol; 2006 Apr; 21(4):280-5. PubMed ID: 16900920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal manifestations of tuberous sclerosis complex: patients' and parents' knowledge and routines for renal follow-up - a questionnaire study.
    Cockerell I; Guenin M; Heimdal K; Bjørnvold M; Selmer KK; Rouvière O
    BMC Nephrol; 2018 Feb; 19(1):39. PubMed ID: 29439672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subependymal Giant Cell Astrocytoma Size Measurement in Tuberous Sclerosis Complex: Noncontrast vs Contrast-Enhanced 3-Dimensional T1-Weighted Magnetic Resonance Imaging (MRI).
    Hill BJ; Gadde JA; Palasis S
    J Child Neurol; 2019 Dec; 34(14):922-927. PubMed ID: 31424303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotype/phenotype in tuberous sclerosis complex: associations with clinical and radiologic manifestations.
    Kothare SV; Singh K; Hochman T; Chalifoux JR; Staley BA; Weiner HL; Menzer K; Devinsky O
    Epilepsia; 2014 Jul; 55(7):1020-4. PubMed ID: 24754401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MR imaging of tuberous sclerosis in neonates and young infants.
    Baron Y; Barkovich AJ
    AJNR Am J Neuroradiol; 1999 May; 20(5):907-16. PubMed ID: 10369365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible prevention of tuberous sclerosis complex lesions.
    Kotulska K; Borkowska J; Jozwiak S
    Pediatrics; 2013 Jul; 132(1):e239-42. PubMed ID: 23733802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recommendations for the radiological diagnosis and follow-up of neuropathological abnormalities associated with tuberous sclerosis complex.
    Rovira À; Ruiz-Falcó ML; García-Esparza E; López-Laso E; Macaya A; Málaga I; Vázquez É; Vicente J
    J Neurooncol; 2014 Jun; 118(2):205-223. PubMed ID: 24771286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex.
    Boer K; Troost D; Timmermans W; Gorter JA; Spliet WG; Nellist M; Jansen F; Aronica E
    Neuroscience; 2008 Sep; 156(1):203-15. PubMed ID: 18706978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012.
    Roth J; Roach ES; Bartels U; Jóźwiak S; Koenig MK; Weiner HL; Franz DN; Wang HZ
    Pediatr Neurol; 2013 Dec; 49(6):439-44. PubMed ID: 24138953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Forehead plaque: a cutaneous marker of CNS involvement in tuberous sclerosis.
    Rama Rao GR; Krishna Rao PV; Gopal KV; Kumar YH; Ramachandra BV
    Indian J Dermatol Venereol Leprol; 2008; 74(1):28-31. PubMed ID: 18187819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain lesions in tuberous sclerosis complex. Review.
    Grajkowska W; Kotulska K; Jurkiewicz E; Matyja E
    Folia Neuropathol; 2010; 48(3):139-49. PubMed ID: 20924998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRI findings reveal three different types of tubers in patients with tuberous sclerosis complex.
    Gallagher A; Grant EP; Madan N; Jarrett DY; Lyczkowski DA; Thiele EA
    J Neurol; 2010 Aug; 257(8):1373-81. PubMed ID: 20352250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The correlation between 1H-MR spectroscopy and clinical manifestation with tuberous sclerosis complex.
    Matsuo N; Imamura A; Ito R; Sugawara K; Takahashi Y; Kondo N
    Neuropediatrics; 2007 Jun; 38(3):126-9. PubMed ID: 17985261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral tuberous sclerosis: MR imaging.
    Nixon JR; Houser OW; Gomez MR; Okazaki H
    Radiology; 1989 Mar; 170(3 Pt 1):869-73. PubMed ID: 2916045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wide spectrum of clinical manifestations in children with tuberous sclerosis complex--follow-up of 20 children.
    Mettin RR; Merkenschlager A; Bernhard MK; Elix H; Hirsch W; Kiess W; Syrbe S
    Brain Dev; 2014 Apr; 36(4):306-14. PubMed ID: 23751858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.